ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 305767 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 305767; 2) Community: the network communities that were significantly associated with the response to NSC 305767; 3) Molecule: the relationships between components within communities and NSC 305767; 4) MDR: the compounds that were significantly associated with the NSC 305767.

NSC Compound Enrichment Correlation
NSC 718579 Null 0.0478540623811426 0.099212087
NSC 718730 Null 0.0478540623811426 0.085336512
NSC 719480 Null 0.0478540623811426 0.0061453992
NSC 725671 5,6-Dihydro-5,11-dioxo-6-(3-amino-1-propyl)-11H-indeno[1,2-c ]isoquinoline hydrochloride 0.0478540623811426 0.30919292
NSC 758662 Lovastatin [USAN] 0.0478540623811426 -0.030612848
NSC 90810 Null 0.0478540623811426 -0.050365912
NSC 95466 PCNU 0.0478540623811426 0.24286186
NSC 760476 5,6,7,8-tetrafluoronaphtho[2,3-c][1,2,5]thiadiazole-4,9-dione 1.37775076606011e-005 0.24381375
NSC 123461 Ethanesulfonic acid, compd. with 4-[[3-[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenyl]-1-oxopropyl]amino]benzenesulfonyl fluoride (1:1) (9CI) 3.06846480290521e-005 0.5146686
NSC 32937 Benzenamine, 4-(9-chloro-10-ethyl-9,10-dihydro-9-acridinyl)-N,N-dimethyl-, dihydrochloride 3.06846480290523e-005 0.27255108
Total:106  Current:105    [First] [Prev] [Next] [Last]